Correction: Global adoption of 6-month drug-resistant TB regimens: Projected uptake by 2026
- PMID: 38295059
- PMCID: PMC10830013
- DOI: 10.1371/journal.pone.0298250
Correction: Global adoption of 6-month drug-resistant TB regimens: Projected uptake by 2026
Abstract
[This corrects the article DOI: 10.1371/journal.pone.0296448.].
Copyright: © 2024 The PLOS ONE Staff. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Erratum for
-
Global adoption of 6-month drug-resistant TB regimens: Projected uptake by 2026.PLoS One. 2024 Jan 5;19(1):e0296448. doi: 10.1371/journal.pone.0296448. eCollection 2024. PLoS One. 2024. PMID: 38180980 Free PMC article.
Similar articles
-
Global adoption of 6-month drug-resistant TB regimens: Projected uptake by 2026.PLoS One. 2024 Jan 5;19(1):e0296448. doi: 10.1371/journal.pone.0296448. eCollection 2024. PLoS One. 2024. PMID: 38180980 Free PMC article.
-
Correction: Cost comparison of nine-month treatment regimens with 20-month standardized care for the treatment of rifampicin-resistant/multi-drug resistant tuberculosis in Nigeria.PLoS One. 2021 Oct 28;16(10):e0259492. doi: 10.1371/journal.pone.0259492. eCollection 2021. PLoS One. 2021. PMID: 34710200 Free PMC article.
-
Correction: Cost comparison of nine-month treatment regimens with 20-month standardized care for the treatment of rifampicin-resistant/multi-drug resistant tuberculosis in Nigeria.PLoS One. 2025 Apr 4;20(4):e0321797. doi: 10.1371/journal.pone.0321797. eCollection 2025. PLoS One. 2025. PMID: 40184342 Free PMC article.
-
Correction: Artificial intelligence enabled parabolic response surface platform identifies ultra-rapid near-universal TB drug treatment regimens comprising approved drugs.PLoS One. 2019 May 30;14(5):e0217670. doi: 10.1371/journal.pone.0217670. eCollection 2019. PLoS One. 2019. PMID: 31145763 Free PMC article.
-
Correction: Challenging drug-resistant TB treatment journey for children, adolescents and their care-givers: A qualitative study.PLoS One. 2024 Feb 21;19(2):e0299482. doi: 10.1371/journal.pone.0299482. eCollection 2024. PLoS One. 2024. PMID: 38381772 Free PMC article.
Cited by
-
BPaLM Regimen Against Drug-Resistant Tuberculosis in India: A Need of the Hour.Cureus. 2024 Sep 1;16(9):e68421. doi: 10.7759/cureus.68421. eCollection 2024 Sep. Cureus. 2024. PMID: 39360094 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources